DOX heads into July with short sellers rebuilding aggressively and options traders stacking put protection at levels rarely seen in the past year — the clearest sign yet that the market is pricing in more pain after a brutal June.
The short-interest story is the dominant angle this week. Shorts have climbed to 8.2% of free float — up 27% in a single week and nearly 69% over the past month. That kind of acceleration is unusual for a mid-cap IT services name. The official FINRA settlement figure from June 15 put short shares at 8.8 million, which aligns closely with the daily estimate, adding confidence to the read. Days-to-cover is running near 6.8, meaning any rapid covering would take more than a week of average volume to unwind.
The borrow market is loose despite that buildup, which is the key nuance. Availability is still running at 564% — meaning there are roughly six shares available to borrow for every one currently lent out. That is well below where it was a month ago (availability was above 1,700% in late May), and the compression has been sharp over the past week alone, falling 51%. Borrow costs have risen alongside, up 20% on the week to 0.56% — still cheap in absolute terms. The picture is one of rising demand meeting a still-ample supply. There is no squeeze dynamic here yet, but the directional trend is notable.
Options tell a more urgent story. The put/call ratio has surged to 3.92, almost two standard deviations above its 20-day mean of 2.15, and closing in on its 52-week high of 4.46. This has not been a gradual drift — the PCR essentially doubled in the two weeks following the mid-June options expiry, jumping from the low 1.3s to above 3.2 by June 22 and continuing higher since. That is a significant repricing of downside risk. Combined with the short-interest acceleration, positioning looks charged rather than complacent.
The Street is cautious but not panicked. Keybanc initiated coverage just days ago with a Sector Weight — neither bullish nor bearish, but hardly a ringing endorsement at current levels. Stifel kept its Buy rating after May's earnings but cut the target sharply from $88 to $71 following the print; the stock has since fallen further to $50.54, meaning even the reduced target implies meaningful upside that the market is clearly not prepared to credit. Barclays has maintained Overweight but cut targets twice since early 2026. On valuation, the P/E has compressed to around 6.7x — cheap in isolation, but the 30-day decline in the multiple has been steady. The ORTEX short score has jumped from 49 to 57.7 over the past two weeks, a move into territory that historically reflects genuine bearish conviction rather than routine hedging. EPS momentum factors rank in the bottom quartile, though forward EPS growth ranks high at the 82nd percentile — a gap that bulls will point to and bears will dismiss as consensus optimism.
The fundamental tension is straightforward. Bulls see a business earning real cash flow, trading at a single-digit multiple, with telecom operators committed to cloud migration spend. Bears see customer concentration, weak near-term demand signals, and a stock that has lost nearly 20% in a month with no obvious catalyst for a reversal. Closest peers ACN and CTSH fell 2% and 5.4% respectively on the week, suggesting sector-wide pressure rather than a DOX-specific idiosyncratic break. EPAM bucked the trend, rising 3.2%, though its business mix is different enough to limit the read-across.
Next up is Q2 earnings on August 5. The last print in May saw a one-day drop of less than 1%, but the February print dropped nearly 10% the following day and held those losses through the week. The question heading into August is whether the positioning reset — short sellers rebuilding, put buyers hedging aggressively — reflects genuine fundamental deterioration or an overshoot that sets up a relief trade if results land in line.
See the live data behind this article on ORTEX.
Open DOX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
